Should You Buy Medtronic Stock as Its Hugo Surgical Robot Gains Ground?
Medtronic has an above-average dividend yield. The company is expanding its robotic-assisted surgery capabilities.
MDT - Medtronic plc
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$98.00
DETAILS
HIGH:
$115.00
LOW:
$83.00
MEDIAN:
$98.00
CONSENSUS:
$98.00
UPSIDE:
5.64%
Stock News
BSX vs. MDT: Which Electrophysiology Stock Is the Better Bet Now?
Boston Scientific faces near-term pressure in electrophysiology, while Medtronic gains share and sees stronger momentum across key franchises.
Autonomix Medical Appoints Former Medtronic Chief Regulatory Counsel Sandra Cohen Kalter to Board of Directors
Appointment adds more than four decades of MedTech leadership, FDA regulatory and strategic transaction experience, including work supporting renal denervation and other category-defining technologies
Medtronic announces FDA clearance for LigaSure™ RAS Maryland instrument on the Hugo™ RAS system
Trusted vessel-sealing technology used in more than 45 million procedures worldwide is now cleared for robotic-assisted surgery in the U.S. GALWAY, Ireland, Sept. 16, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) has cleared the LigaSure™ RAS Maryland jaw device for use with the Hugo™ robotic-assisted surgery (RAS) system.
Medtronic Sees AI, Ablation and Targeted M&A Fueling Growth
Medtronic NYSE: MDT Chief Financial Officer Thierry Piéton said the medical-device maker's focus on acute procedures, expanding innovation pipeline and increased use of targeted acquisitions are supporting its recent growth momentum.
Medtronic plc (MDT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Medtronic plc (MDT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
MiniMed Files Form S-4 Registration Statement in Connection with Medtronic Exchange Offer Announcement
NORTHRIDGE, Calif., Sept. 14, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED) announced that it has filed a Form S-4 Registration Statement today with the Securities and Exchange Commission (the "SEC") in connection with Medtronic plc's ("Medtronic"; NYSE: MDT) offer to exchange up to 225,361,295 shares of MiniMed common stock, representing 80.1% of the total outstanding shares of MiniMed common stock, for outstanding Medtronic ordinary shares that are validly tendered and not validly withdrawn.
Medtronic Launches Exchange Offer to Complete Separation of MiniMed Group, Inc.
Medtronic shareholders can exchange their Medtronic ordinary shares for shares of MiniMed Provides Medtronic shareholders with option for a generally tax-free exchange for U.S. federal income tax purposes GALWAY, Ireland, Sept. 14, 2026 /PRNewswire/ -- Medtronic plc (Medtronic; NYSE: MDT) today announced that it has commenced an exchange offer to split off at least 80.1% of the shares of MiniMed Group, Inc. (MiniMed; Nasdaq: MMED).
Integrated Wealth Concepts LLC Sells 6,025 Shares of Medtronic PLC $MDT
Integrated Wealth Concepts LLC lessened its stake in Medtronic PLC (NYSE: MDT) by 14.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 34,691 shares of the medical technology company's stock after selling 6,025 shares during the
Two Medical Device Dividend Giants, One Better Buy: Medtronic vs. Abbott
Both Medtronic and Abbott have raised their dividends for nearly half a century, but retirement investors with limited capital can only choose one.
Medtronic Raises 2027 Outlook as Broad-Based Growth Gains Momentum
MDT lifts its 2027 outlook as broad-based growth accelerates, but margin pressure and competition could test momentum.
Medtronic Is on the Cusp of Becoming a Dividend King. Is the Stock a Buy for Income Investors?
Factors such as the prospect of slow dividend growth could make Medtronic stock less attractive to income-focused investors. For investors interested in both income and capital growth, much suggests that Medtronic remains a strong choice to buy and hold over the next few years.
Wall Street Isn't Talking About High-Yield Medtronic Stock -- Here's Why It Should Be
Medtronic is one of the world's largest medical device companies. Medtronic has reshaped its business, with a focus on returning to growth.
California State Teachers Retirement System Acquires 156,085,748 Shares of Medtronic PLC $MDT
California State Teachers Retirement System increased its holdings in Medtronic PLC (NYSE: MDT) by 7,655.7% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 158,124,578 shares of the medical technology company's stock after buying an additional 156,085,748 shares during the
Medtronic Touts AI, Robotics and Ablation Growth at Wells Fargo Conference
Medtronic NYSE: MDT executives said the medical device maker is seeing accelerating growth across major franchises and emerging product categories, supported by innovation in artificial intelligence, robotics and new therapies.
Medtronic plc (MDT) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Medtronic plc (MDT) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
2 Beaten-Down Stocks to Buy and Hold for the Next 10 Years
Let's look beyond recent obstacles these companies have encountered.
Is Medtronic Worth Buying as Growth Improves but Risks Stay Elevated?
MDT's stronger growth and earnings outlook improve its case, but margin, currency and execution risks keep investors selective.
Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the appointment of Sean M. Salmon to its Board of Directors, effective September 8, 2026. Mr. Salmon brings over three decades of global leadership experience in the medical device and pharmaceutical industries, culminating in more than 20 years at Medtronic plc (NYSE: MDT). He most recently served as Executive Vice President and President of its Cardiovascular Portf.
Medtronic PLC $MDT Holdings Raised by First Eagle Investment Management LLC
First Eagle Investment Management LLC raised its holdings in shares of Medtronic PLC (NYSE: MDT) by 37.2% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 13,783,983 shares of the medical technology company's stock after purchasing an additional 3,739,288
Price Targets
Medtronic price target raised to $92 from $78 at Deutsche Bank
$92.00
(was $91.50)
Deutsche Bank
Medtronic price target raised to $110 from $100 at UBS
$110.00
(was $92.18)
UBS
Medtronic price target raised to $115 from $100 at Mizuho
$115.00
(was $92.18)
Anthony Petrone
·
Mizuho Securities
Medtronic price target raised to $95 from $80 at Stifel
$95.00
(was $92.04)
Rick Wise
·
Stifel Nicolaus
Medtronic, Inc. (MDT) PT Raised to $104 at Wells Fargo
$104.00
(was $92.04)
Larry Biegelsen
·
Wells Fargo
Medtronic, Inc. (MDT) PT Raised to $99 at Truist Securities
$99.00
(was $92.04)
Richard Newitter
·
Truist Financial
Medtronic price target raised to $100 from $91 at BTIG
$100.00
(was $92.44)
BTIG
Medtronic, Inc. (MDT) PT Raised to $114 at NeedhamMember Login
$114.00
(was $92.02)
Needham
UBS Upgrades Medtronic, Inc. (MDT) to Buy
$100.00
(was $84.22)
Priya Sachdeva
·
UBS
Medtronic price target raised to $91 from $90 at BTIG
$91.00
(was $83.87)
Ryan Zimmerman
·
BTIG
Medtronic price target lowered to $105 from $106 at Evercore ISI
$105.00
(was $81.61)
Evercore ISI
Piper Sandler on Medtronic, Inc. (MDT): 'Warming to the Story but Not Quite There'
$85.00
(was $81.14)
Matt O'Brien
·
Piper Sandler
Medtronic price target lowered to $83 from $84 at Goldman Sachs
$83.00
(was $82.28)
David Roman
·
Goldman Sachs
Medtronic price target lowered to $86 from $95 at Truist
$86.00
(was $81.64)
Truist Financial
Medtronic, Inc. (MDT) PT Lowered to $97 at Bernstein SocGen Group
$97.00
(was $82.54)
Lee Hambright
·
Bernstein
Medtronic price target lowered to $85 from $93 at Baird
$85.00
(was $77.95)
David Rescott
·
Robert W. Baird
Medtronic price target lowered to $85 from $90 at UBS
$85.00
(was $77.95)
Priya Sachdeva
·
UBS
Medtronic, Inc. (MDT) PT Lowered to $88 at Jefferies
$88.00
(was $77.95)
Matthew Taylor
·
Jefferies
Medtronic upgraded to Buy at BTIG on consistent organic growth
$90.00
(was $77.95)
BTIG
Medtronic price target lowered to $80 from $95 at Stifel
$80.00
(was $77.95)
Rick Wise
·
Stifel Nicolaus